Back

Renal and electrolyte safety of acetazolamide Add-On decongestion in heart failure: a systematic review

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Navigating the cardio-renal syndrome (2) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rubiya Ali

Memorial Healthcare System, Pembroke Pines (United States of America)

5 More presentations in this session

Presentation thumbnail
Predicting diuretic resistance without urine output in acute heart failure
Mrs E. Vice (Atlanta, US)
Abstract
Presentation thumbnail
Renal safety of a natriuresis-guided diuretic strategy in hospitalised heart failure
Doctor S. Singh (Hartford, US)
Abstract
Presentation thumbnail
Thiazides attenuate the diuretic response to pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patients
Doctor D. Ceelen (Groningen, NL)
Abstract
Presentation thumbnail
Sustained low-efficiency dialysis for refractory congestion in advanced cardiorenal syndrome: haemodyamics and weight reduction analysis
Doctor G. Mihelcic (London, GB)
Abstract
Presentation thumbnail
Hyperkalemia incidence and recurrence among patients with heart failure - predictors and temporal trends
Doctor F. Lindberg (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
Navigating the cardio-renal syndrome (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources